LONDON - After two years of searching, British Biotech plc finally landed a merger partner, privately held RiboTargets Holdings plc, a structure-based drug discovery specialist that brings £19 million (US$30 million) to add to British Biotech's £32 million cash pile. (BioWorld International) Read More
